Inventor · disambiguated record
Hui Feng
Also filed as: FENG HUI · FENG HUI M · FENG HUI-MING
13 granted patents·31 pending applications·43 citations·filing 2004–2023
87Inventor score
Files withSHANGHAI JUNSHI BIOSCIENCES CO LTD27CHEN RIDONG3INPAQ TECHNOLOGY CO LTD3SHANGHAI JUNSHI BIOSCIENCES INC3JUNSHI BIOSCIENCES CO LTD1
Top patents by PatentIndex Score
44 records- 0189US8236527B2Recombinant production of authentic human proteins using human cell expression systemsCHEN RIDONG·Filed 2009·Granted Aug 7, 2012·20 cites·18 claims
- 0286US10066013B2Anti-PD-1 antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES INC·Filed 2014·Granted Sep 4, 2018·12 cites·7 claims
- 0381US10815302B2Anti-PD-1 antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES INC·Filed 2018·Granted Oct 27, 2020·2 cites·11 claims
- 0478US12110329B2Anti-BTLA antibodySHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Granted Oct 8, 2024·1 cites·15 claims
- 0568US9718870B2OX40L fusion proteins and uses thereofMEDIMMUNE LLC·Filed 2015·Granted Aug 1, 2017·1 cites·36 claims
- 0666US10858447B2Anti-PCSK9 antibody and use thereofJUNSHI BIOSCIENCES CO LTD·Filed 2016·Granted Dec 8, 2020·1 cites·20 claims
- 0765US9828423B2Anti-BLyS antibodyWUHAN THERASOURCE BIOSCIENCES INC·Filed 2013·Granted Nov 28, 2017·3 cites·15 claims
- 0862US2021009688A1Anti-pd-1 antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 0960US7884462B2Insulation covering structure for a semiconductor element with a single die dimension and a manufacturing method thereofINPAQ TECHNOLOGY CO LTD·Filed 2008·Granted Feb 8, 2011·2 cites·8 claims
- 1060US2025346674A1Combination of anti-pd-1 antibody and anti-egfr antibody, and use thereof in treatment of head and neck squamous cell carcinomaSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 1160US2023322929A1Compositions and Methods for Treating Solid Tumors with Anti-BTLA as Mono or Combination TherapySHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 1259US2023019098A1Bivalent compounds, conjugates and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
- 1358US2025333730A1Sirna for inhibiting angptl3 gene expression and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 1457US2024117043A1Bispecific antibody targeting cd112r and tigit and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 1556US2025034254A1Use of anti-pd-1 antibody in combination with chemotherapy in treating esophageal cancerSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 1655US8111126B2Over-current protection device and manufacturing method thereofLI WEN CHIN·Filed 2009·Granted Feb 7, 2012·1 cites·17 claims
- 1755US2015099295A1Recombinant production of authentic human proteins using human cell expression systemsCHEN RIDONG·Filed 2014·Application pending·0 cites
- 1855US2024218066A1Use of anti-pd-1 antibody in combination with first-line chemotherapy in treatment of advanced non-small cell lung cancerSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 1953US12268778B2Bifunctional nucleoside hydrogel, preparation method therefor and use thereofUNIV SICHUAN·Filed 2019·Granted Apr 8, 2025·0 cites·17 claims
- 2053US2023192854A1Anti-btla antibody pharmaceutical composition and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 2153US2024254230A1Method of treating urothelial carcinomaSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 2253US2025122271A1Anti-dkk1 antibody, pharmaceutical composition thereof, and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 2352US2025154275A1Anti-cd3 and anti-cd20 bispecific antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 2452US2024309087A1Anti-cd112r antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 2552US2023322930A1Use of an anti-pd-1 antibody and a cytotoxic anticancer drug in treatment of non-small cell lung cancerSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 2652US2023365691A1Use of anti-pd-1 antibody in treatment of nasopharyngeal carcinomaSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 2751US2023082898A1Use of anti-pd-1 antibody in treatment of tumorsSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 2851US2025127915A1Anti-cldn-18.2 antibody-drug conjugate and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 2950US2013095062A1Recombinant production of authentic human proteins using human cell expression systemsCHEN RIDONG·Filed 2012·Application pending·0 cites
- 3050US2023212292A1Use of anti-pd-1 antibody in treating neuroendocrine tumorsSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 3150US2023212278A1Pharmaceutical composition of anti-il-17a antibodies and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 3250US2024067720A1Anti-tigit antibody pharmaceutical composition and application thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 3349US2024342083A1Anti-pd-1 antibody pharmaceutical composition and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 3449US2023107856A1Use of anti-pd-1 antibody in treatment of malignancySHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 3548US2022363754A1Anti-tigit antibodies and application thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 3647US12209124B2Anti-IL-17A antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2019·Granted Jan 28, 2025·0 cites·15 claims
- 3747US2023295301A1Anti-ctla-4 antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 3846US7741948B2Laminated variable resistorINPAQ TECHNOLOGY CO LTD·Filed 2006·Granted Jun 22, 2010·0 cites·3 claims
- 3946US2022154296A1Use of anti-pd-1 antibody in preparation of medicament for treating solid tumorsSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 4043US2021393777A1Stable preparation comprising anti-pcsk9 antibodySHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 4140US2009233112A1Multilayer zinc oxide varistorLIU SHIH-KWAN·Filed 2008·Application pending·0 cites
- 4237US11267890B2Anti-PD-L1 antibody and application thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2018·Granted Mar 8, 2022·0 cites·17 claims
- 4336US2005212648A1Low-capacitance laminate varistorINPAQ TECHNOLOGY CO LTD·Filed 2004·Application pending·0 cites
- 4423US2009236692A1Rc filtering device having air gap construction for over voltage protectionSU SHENG-FU·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hui Feng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →